| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $5.0B | $5.1B | $4.9B | $4.9B | $4.5B | $4.0B | $1.0B | $0.9B |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | $0.1B | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | $0.5B | $0.5B | $0.5B | $0.4B | $0.1B | $0.0B |
| Net Income | $0.2B | $0.2B | $0.4B | $0.4B | $0.3B | $0.3B | $0.0B | $0.0B |
| EPS (Basic) | $3.20 | $3.47 | $6.61 | $5.66 | $5.13 | $4.03 | $0.69 | $0.41 |
| EPS (Diluted) | $3.20 | $3.43 | $6.56 | $5.61 | $5.07 | $3.99 | $0.68 | $0.40 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $3.8B | $4.1B | $3.7B | $3.4B | $3.3B | $3.0B | $2.7B | $2.4B |
| Current Assets | $2.9B | $3.2B | $2.6B | $2.3B | $2.4B | $2.2B | $1.9B | $1.6B |
| Cash & Equivalents | $0.3B | $0.4B | $0.3B | $0.4B | $0.6B | $0.3B | $0.2B | $0.2B |
| Total Liabilities | $3.7B | $4.0B | $3.6B | $2.7B | $2.4B | $2.4B | $2.3B | $2.1B |
| Current Liabilities | $2.6B | $3.0B | $2.5B | $2.0B | $1.7B | $1.9B | $1.6B | $1.4B |
| Stockholders' Equity | $0.1B | $0.1B | $0.1B | $0.8B | $0.9B | $0.6B | $0.5B | $0.4B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.3B | $0.3B | $0.5B | $0.6B | $0.2B | $0.5B | $0.5B | $-0.1B |
| Investing Cash Flow | $-0.0B | $0.2B | $-0.1B | $-0.2B | $-0.1B | $-0.2B | $-0.2B | $-0.2B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B | $0.1B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $-0.0B | $-0.2B | $-0.5B | $-0.5B | $0.0B | $-0.2B | $-0.2B | $-0.1B |